Women in Science - Beate Mueller on the privilege of bringing solutions closer to patients

Therapy for aggressive brain cancer receives FDA clearance to start phase 1

Neuromuscular diseases in crosshairs in Forge Biologics gene therapy collaboration

Women in Science - Emmanuelle Cameau on growing stronger from challenges

How modern trial designs propel cancer therapies to the market - interview

FDA lifts partial clinical hold on phase 3 low blood sugar treatment

Eli Lilly reports positive phase 3 results for a weekly insulin formulation

Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'

FDA designations boost AI-driven cell therapy approach for Duchenne muscular dystrophy

Eli Lilly's eczema drug receives FDA approval one year after its initial rejection

MinervaX and Wacker Biotech partner to scale up GBS vaccine production

Women in science - Alison O'Neill at YPrime on thinking out loud and collaborating

Eli Lilly expands manufacturing facilities in Ireland with $1.8bn investment

Aurora Biosynthetics launches to boost RNA therapeutics manufacturing in Asia-Pacific

Cellevate bags €3.2 million to smash viral vector manufacturing bottleneck

Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence

Pricing and logistics: The challenges of getting mpox vaccines to the front line

AI study shows GLP-1s could help prevent heart disease in millions

UCB and Biogen announce positive Phase 3 results for dapirolizumab pegol in systemic lupus erythematosus

Vicebio closes $100m financing round to advance multivalent vaccine technology